BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huang YZ, Yang GY, Wang C, Chen XY, Zhang LL. Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis. World J Diabetes 2021; 12(9): 1576-1586 [PMID: 34630909 DOI: 10.4239/wjd.v12.i9.1576]
URL: https://www.wjgnet.com/1948-5182/full/v12/i9/1576.htm
Number Citing Articles
1
Stergios A. Polyzos, Dimitrios G. Goulis, Olga Giouleme, Georgios S. Germanidis, Antonis Goulas. Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver DiseaseCurrent Obesity Reports 2022; 11(3): 166 doi: 10.1007/s13679-022-00474-0
2
Dachuan Jin, Zhongfeng Cui, Shunqin Jin, Tao Zhou, Baoqiang Guo, Peng Gao, Guangming Li. Comparison of efficacy of anti-diabetics on non-diabetic NAFLD: A network meta-analysisFrontiers in Pharmacology 2023; 13 doi: 10.3389/fphar.2022.1096064
3
Federica Perazza, Laura Leoni, Santo Colosimo, Alessandra Musio, Giulia Bocedi, Michela D’Avino, Giulio Agnelli, Alba Nicastri, Chiara Rossetti, Federica Sacilotto, Giulio Marchesini, Maria Letizia Petroni, Federico Ravaioli. Metformin and the Liver: Unlocking the Full Therapeutic PotentialMetabolites 2024; 14(4): 186 doi: 10.3390/metabo14040186
4
Maria Zachou, Pagona Flevari, Narjes Nasiri-Ansari, Constantinos Varytimiadis, Evangelos Kalaitzakis, Eva Kassi, Theodoros Androutsakos. The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative reviewEuropean Journal of Clinical Pharmacology 2024; 80(1): 127 doi: 10.1007/s00228-023-03586-1